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Summary
Functional characterization of a gene often requires the
discovery of the full spectrum of its associated pheno-
types. Mutations in the human GLI3 gene have been
identified in Greig cepalopolysyndactyly, Pallister-Hall
syndrome (PHS), and postaxial polydactyly type-A
(PAP-A). We studied the involvement of GLI3 in addi-
tional phenotypes of digital abnormalities in one family
(UR003) with preaxial polydactyly type-IV (PPD-IV),
three families (UR014, UR015, and UR016) with dom-
inant PAP-A/B (with PPD-A and -B in the same family),
and one family with PHS. Linkage analysis showed no
recombination with GLI3-linked polymorphisms. Fam-
ily UR003 had a 1-nt frameshift insertion, resulting in
a truncated protein of 1,245 amino acids. A frameshift
mutation due to a 1-nt deletion was found in family
UR014, resulting in a truncated protein of 1,280 amino
acids. Family UR015 had a nonsense mutation, R643X,
and family UR016 had a missense mutation, G727R, in
a highly conserved amino acid of domain 3. The patient
with PHS had a nonsense mutation, E1147X. These re-
sults add two phenotypes to the phenotypic spectrum
caused by GLI3 mutations: the combined PAP-A/B and
PPD-IV. These mutations do not support the suggested
association between the mutations in GLI3 and the re-
sulting phenotypes. We propose that all phenotypes as-
sociated with GLI3 mutations be called “GLI3 morpho-
pathies,” since the phenotypic borders of the resulting
syndromes are not well defined and there is no apparent
genotype-phenotype correlation.
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Introduction
The study of natural mutations resulting in clinically
recognized human dysmorphic syndromes has recently
made important contributions to our knowledge of the
potential function of genes in human development (Ep-
stein 1995). In the past 5 years, molecular dysmor-
phology has begun to provide diagnostic tests for the
exact characterization of developmental anomalies.
Mutations in the human transcription regulator gene
GLI3 (fig. 1) are associated with three autosomal dom-
inant phenotypes: the Greig cephalopolysyndactyly syn-
drome (GCPS; MIM175700 ) (Vortkamp et al. 1991;
Wild et al. 1997), Pallister-Hall syndrome (PHS; MIM
146510) (Kang et al. 1997a), and postaxial polydactyly
type A (PAP-A; MIM 147200) (Radhakrishna et al.
1997b). Most of the clinical characteristics of these syn-
dromes are distinct, but all share digital abnormalities.
It has been suggested that there is an association between
the site of GLI3 protein truncation and the phenotypes
in syndromes caused by GLI3 mutations (Biesecker
1997): GCPS is caused by protein truncations before or
within the zinc finger domain (ZFD) (Wild et al. 1997),
PHS by truncations after the ZFD but before the Post
zinc finger domain 1 (Pzf1, or domain 3) (Ruppert et al.
1990), whereas PAP-A is associated with mutations after
domain 3 (Radhakrishna et al. 1997b).
The human GLI3 is homologous to the Drosophila
Cubitus interruptus (Ci) (Orenic et al. 1990). Ci is a
transcription regulator and an important component of
the hedgehog signaling pathway of pattern formation of
limbs and wings (Dominguez et al. 1996). Full-length
Ci (Ci155) is localized in the cytoplasm, where it is an-
chored to the microtubule system. In the absence of
hedgehog, Ci is cleaved by a hedgehog-regulated pro-
tease to generate an amino-terminal fragment (Ci75) con-
taining the ZFD, which is subsequently translocated to
the nucleus where it represses its target genes (Aza-Blanc
et al. 1997; Robbins et al. 1997; Ruiz i Altaba 1997;
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Figure 1 A, Schematic representation of Drosophila Ci protein and its identified domains, protein cleavage region, and microtubular
anchor sequences. B, GLI3 protein showing the homologous domains with Ci. C, Schematic representation of the predicted GLI3 proteins in
five different (GCPS, PHS, PAP-A, PAP-A/B, PPD-IV) autosomal dominant traits. The blackened domain at the carboxyl-terminus of some
predicted mutant proteins depicts the novel abnormal amino acids. The families described here corresponding to the mutant proteins or to the
literature citation are depicted to the right of the schematic of each mutant protein.
Sisson et al. 1997). In contrast, in the presence of hedge-
hog signaling, Ci155 translocates to the nucleus and ac-
tivates transcription. It is not clear whether the human
GLI3 protein undergoes similar proteolytic cleavage, cel-
lular trafficking, and regulation of transcriptional activ-
ity as the Drosophila Ci. However, if this is the case,
then the processing of the predicted truncated GLI3s
found in the various syndromes may be altered and di-
rectly implicated with different GLI3 phenotypes. It has
been shown, by means of truncated GLI3 proteins in
transfection experiments in mammalian cells, that se-
lected GLI3 truncations mimic the DrosophilaCi protein
functions and subcellular localization (Shin et al. 1999).
They showed that full-length GLI3 (which is similar to
Ci155) localizes to the cytoplasm and activates Patched
1 (PTCH1) expression; a mutant truncated GLI3 of the
first 674 amino acids (which is similar to Ci75) localizes
to the nucleus and represses GLI3-activated PTCH1 ex-
pression (Shin et al. 1999).
The associations of different dysmorphic phenotypes
with different GLI3 mutations are made on the basis of
only a few cases; in addition, an amino acid substitution,
P707S, within domain 3, has been found in a patient
with GCPS (Wild et al. 1997).
To further elucidate the involvement of GLI3 muta-
tions in polydactyly syndromes, and to contribute to the
attractive hypothesis of genotype-phenotype correlation
on the basis of sites of the mutations, we have investi-
gated the molecular basis of patients with PAP-A/B, with
preaxial polydactyly type-IV (PPD-IV; MIM 174700)
and with PHS.
Families with PAP-A/B include individuals with both
type A (PAP-A) and type B (PAP-B) (Kucheria et al.
1981). In PAP-A, the extra digit is well formed, artic-
ulates with the 5th or extra metacarpal/metatarsal, and
is usually functional. In PAP-B (pedunculated postmi-
nimus), the extra digit is not well formed and frequently
occurs in the form of a skin tag (Temtamy and McKusick
1969). The PPD-IV family was studied because of the
clinical suggestion that this abnormality may be allelic
to GCPS (Baraitser et al. 1983).
We report that, at least in certain families, PAP-A/B
and PPD-IV are also due to mutations in GLI3. The
location of the mutation and the structure of the pre-
dicted abnormal protein do not conform to the hypoth-
esis suggested by Biesecker (1997); and the genotype-
phenotype correlation, if it exists at all for phenotypes
caused by GLI3 mutations, is not obvious. In addition,
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we propose the term “GLI3 morphopathies” to describe
the spectrum of phenotypes related to mutations in GLI3
(presently including GCPS, PHS, PAP-A, PAP-A/B, and
PPD-IV), and that these various clinical syndromes
represent a continuum of phenotypes with unclear
limitations.
Subjects, Material, and Methods
Family UR003
Family UR003 is from the Gujarat state in western
India and has PPD-IV. The pedigree consists of 35 in-
dividuals including 22 who are affected (partial pedigree
is shown in fig. 2A, and hand/foot phenotypes are shown
in fig. 2D–I). Most affected individuals had bilateral
anomalies in their lower limbs although their hands were
less-severely affected, and some individuals had appar-
ently normal hands. Foot polydactyly was the only ab-
normality in 12 of the 22 affected individuals. The
anomaly ranges from duplication of the big toe(s) (dou-
ble toes) to syndactyly of toes with PAP. Hand poly-
dactyly was not observed without foot polydactyly. A
few individuals showed only foot PAP, whereas 10 per-
sons showed both hand and foot polydactyly. The more-
severely affected individuals with hand polydactyly had
bilateral duplication of the 5th fingers and nails and
unilateral triplication of the 5th finger. One individual
had duplication of 5th-finger nails in one hand and PAP-
B in the other. Most hand abnormalities were combi-
nations of unilateral or bilateral PAP-A or -B. In several
affected individuals, the last toe (postaxially) was dis-
proportionately larger than the previous one. Soft-tissue
syndactyly of 2d and 3d toes was observed in three in-
dividuals. There is, therefore, extensive variability of the
phenotypic features of a single molecular defect in this
family. This trait was disadvantageous to a few of the
affected individuals; however, no surgical corrections
were performed. There were no craniofacial signs, such
as frontal bossing, macrocephaly, hypertelorism, or
broad base of the nose, in any of the individuals with
the digital anomalies.
Family UR014
This three-generation pedigree, also from Gujarat,
consists of a total of 18 individuals; 3 are affected males
and 4 are affected females with dominant PAP-A/B (fig.
3A). Figure 3D–I shows clinical photographs and ra-
diographs of phenotypic characteristics of selected in-
dividuals. All affected individuals examined showed ex-
tra digits in hands and feet. The extra digits were not
well developed in the hands of all affected individuals.
The phenotype was highly variable within the family,
and it ranges from fully bilateral PAP-A in the hands
with normal feet (one individual); PAP-A in the left hand
and PAP-B in the right hand with normal feet (one in-
dividual); bilateral PAP-A in the hands and feet (three
individuals); PAP-A in the right hand and bilateral PAP
of the feet with soft-tissue syndactyly of the 5th and 6th
toes in the right foot (one individual); to bilateral PAP-
A of the hand with soft-tissue syndactyly of the 4th and
5th fingers and normal toes (one individual). X-rays of
selected individuals with a PAP-A functional extra finger
show that the additional fingers articulate with the 5th
metacarpal. Some individuals showed broad thumbs.
Family UR015
This family also shows the phenotype of dominant
PAP-A/B. Among 37 subjects in five generations of this
pedigree from Gujarat (fig. 4A), there were 6 affected
females and 10 affected males. In most affected individ-
uals, polydactyly was observed in both hands and feet
(fig. 4D–G). In this pedigree, one individual was found
to have PAP-B in the right hand and PAP-A in the left
hand with bilateral PAP of the feet. Most affected in-
dividuals could not use or move the 6th fingers. An as-
sociated anomaly observed in this family was soft-tissue
syndactyly. Syndactyly of 2nd and 3rd toes in four in-
dividuals, unilateral syndactyly of 2nd and 3rd toes in
six individuals, and syndactyly of 5th and 6th toes in
four individuals were observed.
Family UR016
This four-generation pedigree, also from Gujarat, con-
sists of 23 individuals, 8 of whom are affected with
dominant PAP-A/B (fig. 5A). Clinical examination re-
vealed the presence of both PAP-A and PAP-B, even
within the same individual (fig. 5D–G). A bilateral
boneless skin tag next to the 5th fingers (pedunculated
postminimus) was observed in individuals with or with-
out PAP of the feet. For example, one individual showed
PAP-A in the left hand and PAP-B in the right hand and
bilateral PAP in his lower limbs. An affected female
showed PAP-A in her hands without any foot anomaly.
The remaining affected individuals showed PAP-A of the
upper and lower extremities.
Most affected individuals in the three families
(UR014, UR015, and UR016) with PAP-A/B could not
normally flex their additional fingers; hence, the extra
fingers were not functional. In several individuals, the
additional 6th digit was connected to the 5th finger with
soft tissue only. No recognizable PAP-B polydactyly in
the lower extremities was observed in any of the mem-
bers of these families. All affected individuals with foot
polydactyly had fully developed extra toes, and, in some
instances, the additional 6th toe was larger than the 5th.
The PAP trait was disadvantageous in most of the af-
fected individuals; however, surgical corrections were
performed in only a few of them. None of the affected
Figure 2 A, Partial pedigree of UR003 with PPD-IV. Affected individuals are shown with blackened symbols, and normal individuals are shown with unblackened symbols.B, Sequence comparison
of a normal and mutant partial chromatograph of DNA from family UR003. The insertion of a C at nucleotide position 3647 of human GLI3 is shown. C, Comparison of translated products of
normal and mutant human GLI3 alleles. The mutated protein is predicted to terminate at codon 1246 after the addition of 30 novel amino acids. D–I, Clinical photographs of six different affected
individuals from family UR003, demonstrating the phenotypic variability.
Figure 3 A, Partial pedigree of family UR014 with PAP-A/B. Affected individuals are shown with blackened symbols. B, Partial sequence of normal and PAP-A/B mutant from family UR014
showing deletion of G at nucleotide 3707. C, Comparison of normal and derived amino acid sequences due to the frameshift deletion mutation. The truncated protein is of 1281 amino acids after
addition of 45 novel codons. D–I, Selected clinical and x-ray photographs from family UR014.
Figure 4 A, Partial pedigree from family UR015 with PAP-A/B phenotype. B, Partial nucleotide sequence from family UR015 showing the substitution of 1927CrT in GLI3, resulting in a stop
codon (R643X). C, Comparison of translation products of the normal and mutated GLI3 allele. The truncated protein terminates at codon 643. D–G, Selected clinical photographs of different
members of family UR015.
Figure 5 A, Partial pedigree of family UR016 with PAP-A/B phenotype. B, Comparison of normal and mutant nucleotide sequence in family UR016 shows a missence mutation resulting in a
GrA transition 2179GrA, and the amino acid substitution G727R. C, Comparison of normal and derived amino acid sequences due to the missense mutation G727R. D–G, Selected clinical
photographs of three affected individuals of family UR016. In panel D, the area of the pedunculated postminimus in the left hand of this individual is enlarged. H, Amino acid sequence comparisons
of domain 3 from several members of the GLI family of proteins from different species. The conserved amino acid G727 mutated in family UR016, and the conserved P707 mutated in a reference
patient with GCPS (Wild et al. 1997) are shown.
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individuals in these pedigrees had any recognizable cra-
nial or dental anomaly.
After we received informed consent, we collected
blood samples from 66 affected and 22 normal individ-
uals from these four pedigrees. Clinical information and
photographs were collected from all affected individuals
included in the study. Hand and foot x-rays were taken
from selected individuals.
Family GVA02
The DNA of a patient with PHS (“patient-2”) from
family GVA02, who had been referred to the Medical
Genetics Clinic of the University Hospital of Geneva,
was also examined. A detailed description of the PHS
phenotype of this patient and the family history were
reported (Verloes et al. 1995).
Polymorphisms and Linkage Analysis
Genomic DNA was purified from peripheral blood
lymphocytes according to standard SDS-proteinase-K
and phenol/chloroform extraction method. DNA poly-
morphisms were analyzed by PCR amplification of
short-sequence repeats. Polymorphic markers from chro-
mosome 7p (D7S2848, D7S526, D7S795, D7S528,
D7S521, D7S691, D7S667, and D7S478) were selected
from the Ge´ne´thon and the Cooperative Human Linkage
Center collection (Murray et al. 1994; Dib et al. 1996)
and were used as described (Radhakrishna et al. 1997a);
in addition, two microsatellite polymorphisms—B48
and B81—within the GLI3 gene were also used (Kang
et al. 1997b). One oligonucleotide primer of each marker
was labeled with g32P-ATP by means of T4 polynucle-
otide kinase. PCR amplifications and scoring of the gen-
otypes were performed as described (Blouin et al. 1995).
Linkage analysis was performed for markers within
and around the GLI3 gene on chromosome 7p. Family
information and marker genotypes were stored in ped-
igrees in the computer program Cyrillic (Cherwell). Two-
point linkage analysis was performed by means of the
MLINK and LINKMAP programs of LINKAGE v5.2
(Lathrop et al. 1984) and FASTLINK v3.0 (Cottingham
et al. 1993) software packages. Maximum LOD and
location scores were calculated for each marker locus by
assuming autosomal dominant mode of inheritance with
100% penetrance. For all polymorphic markers, allele
frequencies were kept equal.
Mutation Analysis
Genomic DNA from normal and affected individuals
of the families described was PCR-amplified, using oli-
gonucleotide primers, for 38 different genomic regions
covering the entire coding sequence of GLI3 and all the
splice junctions (Wild et al. 1997; Kang et al. 1997a).
These PCR products were first screened for mutations
by use of SSCP (Orita et al. 1989). The PCR products
were denatured with an equal volume of 95% forma-
mide, .05% xylene cyanol, and .05% bromophenol blue,
for 15 minutes at 94C, and loaded on a 12.5% GeneGel
Excel (Pharmacia Biotech). Electrophoresis was at 600V
at 12C for 2–3 h, depending on the size of the PCR
product. The gels were stained by DNA silver staining
(Pharmacia Biotech). SSCP variants were purified and
directly sequenced in both directions with appropriate
primers by means of an ABI377 sequencer. Mutant al-
leles were also cloned by use of the Original TA cloning
kit (Invitrogen) after PCR amplification, purified as de-
scribed elsewhere (Mehenni et al. 1998), and subjected
to nucleotide sequencing.
Results
Mapping of Phenotypes to the Candidate 7p Region
that Includes GLI3
Because mutations in the GLI3 gene were identified
in families with PAP-A (Radhakrishna et al. 1997b), we
first performed linkage analysis in the candidate genomic
region of chromosome 7p in which the GLI3 gene is
located, using DNA from families UR003, UR014,
UR015, and UR016. A maximum LOD score was ob-
tained with marker D7S521 ( ; ),Z = 8.12 v = .00max
which is located 0.42 cM centromeric to GLI3. No re-
combination was observed between this marker and the
polydactyly phenotypes in all four families. The Zmax for
families UR003, UR014, UR015, and UR016 were 3.91,
2.11, 1.11, and 0.99, respectively. We then used two
microsatellite polymorphisms within the GLI3 gene
(Kang et al. 1997b) in these families. No recombination
with the GLI3 markers and the polydactyly phenotypes
was observed in the informative members of these four
families. The Zmax at for the GLI3 markers werev = .00
UR003: 5.51, UR014: 2.11, and UR015: 1.66. Family
UR016 was not informative and yielded a .Z = 0.25max
These results suggested that the GLI3 gene was a strong
candidate for the phenotypes in these four families and,
subsequently, mutation analysis was performed.
Mutation Search in the GLI3 Gene
We then performed mutation analysis in all the coding
regions and intron-exon junctions of the GLI3 gene in
an affected and normal member of each family: UR003
with PPD-IV, UR014, UR015, UR016 with PAP-A/B,
and GVA02 with PHS. The mutation search included
SSCP and nucleotide sequencing of the abnormally mi-
grating amplimers.
A single nucleotide insertion of C at GLI3 cDNA po-
sition 3647 in exon 15 (numbering as in GenBank ac-
cession numbers M57609–M34366) was found in het-
erozygosity in all affected members of family UR003
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Figure 6 A, Partial sequence of normal and mutant GLI3 gene
from the patient with PHS from family GVA02, showing the nucleotide
substitution 3439GrT, which results in a stop codon (E147X). B,
Comparison of normal and derived amino acid sequences due to the
nonsense mutation E147X.
with PPD-IV. The insertion occurred in codon 1216 of
the 1596–amino acid GLI3 in a (C)3 tract and results
in a frameshift and stop codon at position 1245 after
the addition of 30 novel amino acids at the carboxyl-
terminus (fig. 2B–C).
In all affected members of family UR014 with PAP-
A/B, a single nucleotide deletion of G in exon 15 was
found in heterozygosity at position 3707 of GLI3 cDNA.
This deletion occurred at codon 1236 in a (G)2 tract of
one allele of GLI3, and this frameshift resulted in a stop
codon at 1281 after the addition of 45 novel amino acids
at the carboxyl-terminus (fig. 3B–C).
In the affected members of family UR015 with PAP-
A/B, a CrT substitution was identified in heterozygosity
in exon 13 at nucleotide position 1927 (1927CrT). This
results in a nonsense codon CGArTGA, which causes
a premature stop at amino acid position 643 (R643X)
(fig. 4B, C). The predicted truncation of the protein oc-
curs between the zinc finger and domain 3 (or Pzf1) of
GLI3.
Family UR016 showed a GrA substitution at nucle-
otide position 2179 of one GLI3 allele in all affected
individuals. This results in the missense substitution Gly-
cinerArginine at codon 727 (G727R) (fig. 5B, C). This
mutation occurred in domain 3 (or Pzf1), which is con-
served in several species (fig. 5H). G727 is invariant in
all domains 3 of the GLI family of proteins examined.
No other mutation was identified in the entire coding
region of this GLI3 allele. This exclusion was done not
only by SSCP but by nucleotide sequencing of all am-
plicons from an affected individual of family UR016.
All the above mutations were present only in the af-
fected individuals of these families and were absent in
the unaffected members of these families. In addition,
none of 100 unrelated normal individuals from the Gu-
jarat region of India showed these mutations.
In patient GVA02, who reportedly had PHS (Ver-
loes et al. 1995), a GrT substitution was identified
in heterozygosity in exon 15 at nucleotide position
3439 (3439GrT). This results in a nonsense codon
GAGrTAG that causes a premature stop at amino acid
position 1147 (E1147X) (fig. 6A, B). The predicted trun-
cation of the protein occurs after domain 5 of GLI3.
This mutation was not present in the DNA of the parents
and, therefore, had occurred de novo. In addition, this
mutation was not found in the DNA of 100 normal
Central European control subjects.
A single nucleotide variant GrT at position 4774 of
the GLI3 cDNA, resulting in a nonsense codon
GAArTAA (E1592X), was found in some normal in-
dividuals from India. This polymorphism will result in
a truncated GLI3 missing only five amino acids in the
carboxyl-terminus (fig. 1).
Discussion
The present mutation search adds two additional
dominantly inherited phenotypes—PPD-IV and PAP-
A/B—which are due to mutations in the GLI3 transcrip-
tion regulator, thus extending the phenotypic spectrum
(from 3 to 5) associated with GLI3 mutations.
That certain forms of the PAP-A/B phenotype are due
to mutations in GLI3 is not entirely surprising, since
some members of these families display only the PAP-A
phenotype. It is of interest, however, that there are in-
dividuals with PAP-A in one hand and PAP-B in the
other. This strongly suggests that the final phenotypic
outcome may be due (in addition to the GLI3 mutations)
to environmental or stochastic factors.
Remarkably, it has been suggested (Baraitser et al.
1983) that PPD-IV and GCPS may have the same mo-
lecular pathogenesis, since the digital changes of the two
conditions are similar, although there are no craniofacial
anomalies observed in PPD-IV. PPD-IV is characterized
by PAP of the hand and PPD/PAP of the foot (Temtamy
and McKusick 1978). In general, the deformities are
more severe in the feet than in the hands. The thumb
shows only the mildest degree of duplication, and syn-
dactyly of various degrees affects fingers 3 and 4. Hand
PAP is also occasionally present. The foot malformations
are more penetrant and consist of duplication of part or
all of the first toes and syndactyly of all the toes; PAP
is also usually present (Reynolds et al. 1984). This dom-
inant phenotype, also known as uncomplicated poly-
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syndactyly type 1, or crossed polydactyly (CP1), due to
the manifestation of polydactyly and syndactyly simul-
taneously, was defined as coexistence of PPD and PAP
with discrepancy in the axis of polydactyly between the
hands and the feet (Ishikiriyama et al. 1991).
The position of the GLI3 mutations found in this study
does not conform to the hypothesis that defined trun-
cations of the GLI3 protein are associated with specific
phenotypes (Biesecker 1997; Radhakrishna et al. 1997b;
Shin et al. 1999). More specifically: (1) The truncating
nonsense mutation in codon 643 detected in family
UR015 with PAP-A/B (fig. 1 and fig. 4B, C) is against
the hypothesis that truncated GLI3 proteins that contain
domain 3 are associated with PAP-A, whereas those with
truncations upstream of domain 3 but containing the
ZFD domain are associated with PHS. (2) The nonsense
mutation found in the PHS patient would result in a
truncated protein at codon 1147, which is in the C-
terminal 3d of the protein well beyond the domain 5
(fig. 1 and fig. 6A, B). (3) The PPD-IV–associated mu-
tation in family UR003 will truncate the protein at co-
don 1245 and that of PAP-A/B–associated mutation in
family UR014 would result in a truncation at codon
1280 (fig. 1; fig. 2B, C; and fig. 3B, C). Although the
novel amino acids at the C-termini of these aberrant
proteins are different, the close position of these two
mutations would predict a similar phenotype. (4) The
amino acid substitution G727R in the UR016 family
with PAP-A/B occurs in the well-conserved domain 3
(fig. 1 and fig. 5B, C, and H). Amino acid G727 is an
invariant residue in all homologous proteins. If this mu-
tation completely abolishes the function of GLI3, then
the suggestion that haploinsufficiency of GLI3 is related
to GCPS (Shin et al. 1999) may not be valid. Another
amino acid substitution, P707S, at the invariant P707
residue of domain 3 has been found in a patient with
GCPS (Wild et al. 1997). If these mutations result in a
gain-of-function, then the expectation would be that
these two patients would show similar phenotypes. We
conclude from these phenotype-genotype observations
that a simple correlation of the position of the GLI3
mutation and the resulting phenotype is far from
satisfactory.
Several mouse phenotypes have been associated with
mutations of GLi3 (see Jackson Laboratory database).
These mutations, which affect the skeleton, eye, tail, and
other appendages, are extra toes Xt (Johnson 1967; Hui
and Joyner 1993); anterior digit deformity, recessive
(add) (van der Hoeven et al. 1993); brachyphalangy,
dominant (bph) (Johnson 1969); and polydactyly Na-
goya, dominant (pdn) (Schimmang et al. 1994; Thien
and Ruther 1999). These mutants display phenotypic
variability of expression, and there is no apparent cor-
relation between the site of mutation and the resulting
phenotype. The Xt spontaneously induced mutation that
occurred in a (C3Hx101)F2 mixed background shows
variable expressivity and severity in affected homozy-
gous and heterozygous mice. It is likely that the genetic
background may contribute to the modification of the
phenotype.
We propose that the syndromes associated with GLI3
mutations could be collectively called “GLI3 morpho-
pathies.” This term would cover, at present, five phe-
notypes—GCPS, PHS, PAP-A, PAP-A/B, and PPD-
IV—and could be extended to other conditions yet un-
identified. Since there is not an obvious phenotype-
genotype correlation of GLI3 mutations and clinical
outcome, and the “borders” of the phenotypic charac-
terization among the different syndromes are not clear,
we favor the designation of GLI3 morphopathies.
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